๐Ÿ”Ž Trials Near Me

Home โ€บ Melanoma โ€บ Utah

Melanoma clinical trials in Utah

26 studies for Melanoma are looking for participants at sites in Utah.

Cities in Utah

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • University of Utah Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06246916

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT05136196

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

  • Primary Children's Hospital, Salt Lake City
RecruitingPhase 2
Up to age 25 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT07621614

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  • Intermountain Health, Salt Lake City
RecruitingPhase 3
Ages 18 to 70 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT05727904

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • University of Utah - Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT05267626

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 15, 2026 ยท NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Utah Cancer Specialists, Salt Lake City
RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Sep 14, 2026 ยท NCT05059444

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 4, 2026 ยท NCT07287917

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Aug 31, 2026 ยท NCT05896839

Project: Every Child for Younger Patients With Cancer

  • Primary Children's Hospital, Salt Lake City
RecruitingObservational study
Up to age 25 ยท All sexes ยท Updated Aug 25, 2026 ยท NCT02402244

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 11, 2026 ยท NCT06242470

Rural Adult and Youth Sun Protection Study

  • University of Utah, Salt Lake City
RecruitingHealthy volunteers welcome
Ages 3 to 7 ยท All sexes ยท Updated Aug 10, 2026 ยท NCT06439979

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 10, 2026 ยท NCT06880549

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Aug 5, 2026 ยท NCT06330064

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 3, 2026 ยท NCT06270706

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Recruiting
Ages 18 and older ยท All sexes ยท Updated Jul 10, 2026 ยท NCT07556380

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Jul 2, 2026 ยท NCT06365619

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated May 15, 2026 ยท NCT05379985

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Recruiting
Ages 18 and older ยท All sexes ยท Updated Apr 30, 2026 ยท NCT05297734

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

  • University of Utah Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Feb 25, 2026 ยท NCT05549297

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Dec 17, 2025 ยท NCT03567889

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Dec 3, 2025 ยท NCT06194929

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

  • Huntsman Cancer Institute - University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 29, 2025 ยท NCT06249048

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Salt Lake City
RecruitingObservational study
All ages ยท All sexes ยท Updated Oct 28, 2025 ยท NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Intermountain Medical Center, Murray
  • Huntsman Cancer Institute (The University of Utah), Salt Lake City
Recruiting
Ages 18 and older ยท All sexes ยท Updated Nov 27, 2024 ยท NCT03860883

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.